95493 ⎘
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings Peri-condensed systems
SUBSTITUTED HETEROAROMATIC AMINES AND USES THEREOF
#2TRICYCLIC COMPOUNDS AND USES THEREOF
#3SOLID FORMS OF A MACROCYCLIC COMPOUNDS AS CFTR MODULATORS AND THEIR PREPARATION
#4LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND
#5HETEROCYCLIC COMPOUNDS USEFUL FOR TREATMENT OF CANCERS
#6ORGANIC LIGHT-EMITTING DEVICE
#7ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#8RARE EARTH COMPLEX
#9HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF
#10FOUR-MEMBERED FUSED RING COMPOUND AND PREPARATION METHOD AND USE THEREOF
#11HIGH ACTIVITY STING PROTEIN AGONIST
#12SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT
#13MACROCYCLIC LRRK2 KINASE INHIBITORS
#14HIGHLY ACTIVE STING PROTEIN AGONIST COMPOUND
#15Nitrogen-Containing Heterocyclic Compound, Pharmaceutical Compositions thereof and Use thereof
#16HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS
#17FUSED TRICYCLIC CYCLIN-DEPENDENT KINASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
#18ORGANIC COMPOUND, OPTOELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE OPTOELECTRONIC DEVICE
#19Process for the preparation of cyclic depsipeptides
#20NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#21TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY
#22HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER
#23ORGANIC COMPOUNDS, MIXTURES, AND USES THEREOF IN ORGANIC ELETRONIC DEVICES
#24Inhibitors of Glucose-6-phosphate Dehydrogenase and Uses Thereof
#25MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#26INDOLO HEPTAMYL OXIME ANALOG CRYSTAL AS PARP INHIBITOR AND METHOD FOR PREPARING SAME
#27ORGANIC LIGHT EMITTING ELEMENT
#28MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#29GRANZYME B DIRECTED IMAGING AND THERAPY
#30TRICYCLIC PYRIDONES AND PYRIMIDONES
#31ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT
#32PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH
#33LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME
#34ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#35MACROCYCLES AS FACTOR XIA INHIBITORS
#36OXYGEN LINKED PYRIMIDINE DERIVATIVES
#37LIGHT EMITTING DEVICE AND POLYCYCLIC COMPOUND FOR THE SAME
#38INDOLO HEPTAMYL OXIME ANALOGUE AS PARP INHIBITOR
#39COMPOUNDS AND METHODS FOR TARGETING HSP90
#40METHOD FOR INTRODUCING DEUTERATED LOWER ALKYL INTO AMINE MOIETY OF COMPOUND CONTAINING SECONDARY AMINE
#41METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINEDIAMINE COMPOUNDS
#42TRICYCLIC COMPOUNDS AS STING AGONISTS, AND PREPARATION METHODS AND MEDICINAL USES THEREOF
#43Analogues and derivatives of cephalotaxine and methods for making and using the compounds
#44Process for the preparation of cyclic depsipeptides
#45CFTR REGULATORS AND METHODS OF USE THEREOF
#46Fused tricyclic heterocycle compounds and therapeutic uses thereof
#47Antibiotic resistance breakers
#48Tricyclic heterocycles as BET protein inhibitors
#49Organic electroluminescence device and polycyclic compound for same
#50Reagents and methods for analysis of proteins and metabolites targeted by covalent probes
#51Dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitor
#52QUINOLONE COMPOUND
#53Granzyme B directed imaging and therapy
#54Compounds and methods for targeting HSP90
#55Process for the preparation of cyclic depsipeptides
#56Heterocyclic compounds as pad inhibitors
#57Pyridinium oxazole dyad scaffold and a process for preparation thereof
#58Tricyclic heterocycles as BET protein inhibitors
#59Benzoimidazole derivatives as PAD4 inhibitors
#60Macrocyclic indole derivatives
#61Macrocycles as factor XIA inhibitors
#62Oxygen linked pyrimidine derivatives
#63QUINOLONE COMPOUND
#64PRC1 inhibitors and methods of treatment therewith
#65Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#66Oxazolidinones and pharmaceutical compositions thereof for treating bacterial infections, including infection of
#67Reagents and methods for analysis of proteins and metabolites targeted by covalent probes
#68Pyridinium oxazole dyad scaffold and a process for preparation thereof
#69Heterocyclic compound and organic light-emitting element using same
#70Tricyclic heterocycles as BET protein inhibitors
#71Bacterial topoisomerase I inhibitors with antibacterial activity
#72Process for the preparation of cyclic depsipeptides
#73QUINOLONE COMPOUND
#74CFTR regulators and methods of use thereof
#75Organic light emitting element
#76HIV REPLICATION INHIBITOR
#77Tricyclic heterocycles as BET protein inhibitors
#78Heterocyclic compounds with dibenzazapine structures
#79Tricyclic PI3K inhibitor compounds and methods of use
#80Benzoimidazole derivatives as PAD4 inhibitors
#81Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereof
#82Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
#83Tricyclic heterocycles as bet protein inhibitors
#84Solid-state image sensor, photoelectric conversion film, electron blocking layer, imaging apparatus, and electronic device
#85Macrocycles as factor XIa inhibitors
#86Heterocyclic compound and organic electroluminescence device including the same
#87Compositions of protein receptor tyrosine kinase inhibitors
#88Bacterial topoisomerase I inhibitors with antibacterial activity
#89STABLE VIOLET-BLUE TO BLUE IMIDAZOLIUM COMPOUNDS
#90Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#91Substituted quinoxalines as PDE-10 inhibitors
#92Macrocycles as factor XIa inhibitors
#93Tetrazolones as a carboxylic acid bioisosteres
#94QUINOLONE COMPOUND
#95Macrocyclic quinazole derivatives and their use as MTKI
#96Inhibitors of HIF prolyl hydroxylase
#97Tricyclic heterocycles as BET protein inhibitors
#98Tricyclic heterocycles as BET protein inhibitors
#99Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound
#100Condensed cyclic compound, composition including the condensed cyclic compound, organic light-emitting device including the condensed cyclic compound, and method of manufacturing the organic light-emitting device
#101HETEROARYL COMPOUNDS FOR KINASE INHIBITION
#102Tricyclic heterocycles as bet protein inhibitors
#103Compounds for electronic devices
#104PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES
#105Materials for organic electroluminescent devices
#106Heteroaromatic derivatives and their use as pharmaceuticals
#107Macrocycles as factor XIa inhibitors
#108R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
#109QUINOLONE COMPOUND
#110ALKOXYCARBONYL HEMIACETAL-TYPE ESTER PRODRUG OF PYRIDONE CARBOXYLIC ACID ANTIBACTERIAL DRUG
#111NOVEL COMPOUND WITH ANTIBACTERIAL ACTIVITY
#112NOVEL COMPOUNDS AS RESPIRATORY STIMULANTS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES
#113Heterocyclic compound and organic light-emitting element using same
#114Heterocyclic compound and organic light-emitting element using same
#115Heterocyclic compound and organic light-emitting element using same
#116Polymorphs of 2-(4-(2-(1-(isopropyl-3-methyl-1H-1,2,4,triazol-5-yl)-5,6-dihydrobenzo[f] imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof
#117Heterocyclic compound and organic light-emitting element using same
#118Tetrazolones as a carboxylic acid bioisosteres
#119QUINAZOLINE DERIVATIVES
#120Tricyclic heterocycles as BET protein inhibitors
#121Antiviral compounds highly effective as HCV-NS5A inhibitor
#122Near infrared label and methods of use thereof
#123Tricyclic indole Mcl-1 inhibitors and uses thereof
#124MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME
#125Tricyclic heterocycles as BET protein inhibitors
#126Macrocycles as factor XIa inhibitors
#127Organic thin film transistor
#128Tricyclic heterocycles as BET protein inhibitors
#129Condensed-cyclic compound and organic light-emitting device including the same
#130Cyclic -acyl -amino phenol CBI derivative
#131Biologically active macrolides, compositions, and uses thereof
#132HIV REPLICATION INHIBITOR
#133OXAZOLIDINONE-QUINOLONE HYBRID ANTIBIOTICS
#134Materials for organic electroluminescent devices
#135Compounds for the treatment of hepatitis C
#136Macrocycles as factor XIa inhibitors
#137Quinolone compound
#138Compositions of protein receptor tyrosine kinase inhibitors
#139Substituted quinolines as PDE-10 inhibitors
#140Polymorphs of 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazole-5-yl)-5,6-dihydrobenzo[F]imidazo [1,2-D][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof
#141Benzimidazole derivatives useful TRPM8 channel modulators
#142Macrocycles as factor XIa inhibitors
#143Cyclic prodrugs of duocarmycin analogs
#144Cyclic P1 linkers as factor XIa inhibitors
#145Pseudorotaxanes, rotaxanes and catenanes formed by metal ions templating
#146Tricyclic heterocycles as BET protein inhibitors
#147QUINOLONE COMPOUND
#148Antiviral compounds highly effective as HCV-NS5A inhibitor
#149Pseudorotaxanes, rotaxanes and catenanes formed by metal ions templating
#150INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#151Tricyclic heterocycles as bet protein inhibitors
#1523-cyano-quinoline derivatives with antiproliferative activity
#153Macrocyclic quinazole derivatives and their use as MTKI
#154Antibiotic conjugates directly linked with steroid drugs
#155Biologically active macrolides, compositions, and uses thereof
#156Macrocycles as factor XIa inhibitors
#157Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof
#158Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases
#159Quinolone compound
#160Cyclic P1 linkers as factor XIa inhibitors
#161Fused Substituted Aminopyrrolidine Derivative
#162Compounds Useful For Making HCV Protease Inhibitors
#163Diazonamide analogs
#164ANTIVIRAL AND ANTIMICROBIAL COMPOUNDS
#165Biodegradable polymer—bioactive moiety conjugates
#166Macrocyclic compounds and methods for their production
#167Spirocyclic aminoquinolones as GSK-3 inhibitors
#168Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device
#169Oxazolidinone-quinolone hybrid antibiotics
#170Benzimidazole derivatives useful as TRPM8 channel modulators
#171Indolophenoxazine compound and organic light emitting device using the same
#172Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions
#173Tricyclic indole derivatives useful endothelial lipase inhibitors
#174Inhibitors of human immunodeficiency virus replication
#1753-cyano-quinoline derivatives with antiproliferative activity
#176Cyclic amides
#177Oxygen linked pyrimidine derivatives
#178Solid state forms of macrocyclic kinase inhibitors
#179Aminopyrimidine derivatives as LRRK2 modulators
#180Compounds for the treatment of hepatitis C
#181Tricarbonyl technetium-99m, rhenium-185/187, or rhenium-188 labeled cyclic RGD derivatives and uses thereof
#182DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)
#183Fused substituted aminopyrrolidine derivative
#184Bridged triarylamines and -phosphines as materials for electronic devices
#185Compounds for electronic devices
#186Macrocycles as factor XIa inhibitors
#187NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX
#188Diazonamide analogs
#189Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
#190Compound and methods for its production
#191Heterocyclic compounds and methods of use
#192Oxygen linked pyrimidine derivatives
#193Compounds for the reduction of beta-amyloid production
#194Heteroalkyl linked pyrimidine derivatives
#195Compounds as respiratory stimulants for treatment of breathing control disorders or diseases
#196Oxazolidinone-quinolone hybrid antibiotics
#197ANTIVIRAL THERAPEUTIC AGENTS
#198R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
#199Fused substituted aminopyrrolidine derivative
#200Compounds for the treatment of hepatitis C
#201Redox drug derivatives
#202Macrocycles as factor XIa inhibitors
#203Aminopyrimidine derivatives as LRRK2 inhibitors
#204Compositions of protein receptor tyrosine kinase inhibitors
#2052-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours
#206Biodegradable polymer—bioactive moiety conjugates
#207Quinolone analogs and methods related thereto
#208Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors
#209Substituted pyrrolidine derivative
#210PERFLUORO MACROCYCLES IN 18F-LABELLING OF MACROMOLECULES
#211HYDRAZIDE COMPOUNDS AND USES THEREOF
#212Hydroxamate-Based Inhibitors of Deacetylases
#213Spirocyclic aminoquinolones as GSK-3 inhibitors
#214Benzimidazole derivatives useful as TRPM8 channel modulators
#215Benzimidazole derivatives useful as TRPM8 channel modulators
#216Inhibitors of human immunodeficiency virus replication
#217Biologically active macrolides, compositions, and uses thereof
#218Inhibitors of human immunodeficiency virus replication
#2192-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as Met kinase inhibitors for the treatment of tumours
#220KYNURENINE-AMINOTRANSFERASE INHIBITORS
#2217-cycloalkylaminoquinolones as GSK-3 inhibitors
#222Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
#223Heterocyclic urea derivatives and methods of use thereof
#224MACROCYCLIC QUINAZOLE DERIVATIVES AND THEIR USE AS MTKI
#225Quinazoline derivatives
#226L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX
#227L-threonine derivatives of high therapeutic index
#2283-cyano-quinoline derivatives with antiproliferative activity
#229Method for producing quinolone carboxylic acid derivative
#230PROCESS FOR THE PREPARATION OF AN ANTIBACTERIAL QUINOLONE COMPOUND
#231And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate
#2329-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
#233L-Threonine derivatives of high therapeutic index
#234Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#235MACROCYCLIC GHRELIN RECEPTOR ANTAGONISTS AND INVERSE AGONISTS AND METHODS OF USING THE SAME
#236Heteroalkyl linked pyrimidine derivatives
#237Inhibitors of Checkpoint Kinases
#238Antiviral therapeutic agents
#2397-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
#240QUINOBENZOXAZINE ANALOGS AND METHODS OF USING THEREOF
#241Quinolone analogs and methods related thereto
#242Oxygen linked pyrimidine derivatives
#243Process For Obtaining Levofloxacin Free From Salts
#244Pyridazine compounds and methods
#245Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#246SUBSTITUTED-DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
#247HCV NS5B inhibitors
#2483-cyano-quinoline derivatives with antiproliferative activity
#249Process for the preparation of levofloxacin hemihydrate
#250Substituted pyrrolidine derivative
#251Aminoquinolones as GSK-3 inhibitors
#252Process for the Preparation of Levofloxacin Hemihydrate
#253Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
#254Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#255Pyridobenzoxazine derivative
#256Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#257Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
#258L-Threonine derivatives of high therapeutic index
#259Pure levofloxacin hemihydrate and processes for preparation thereof
#260Quinobenzoxazine analogs and compositions
#261Macrocyclic quinazoline derivatives as antiproliferative agents
#262Compounds with high therapeutic index
#263Biologically active macrolides, compositions, and uses thereof
#264Synthesis, characterization and biological action of optically active isomers of floxacins
#265Substituted quinobenzoxazine analogs and methods of using thereof
#266Process for producing benzoxazine derivative and production intermediate thereof
#267Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
#268Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
#269Preparation of levofloxacin and forms thereof
#270Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#27110-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium
#272Methods for the purification of levofloxacin
#273Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
#274Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
#275Process for producing benzoxazine derivative and production intermediate thereof
#276Macrocyclic indole derivatives